• Economy
  • Editor’s Pick
Money Rise Today – Investing and Stock News
  • Investing
  • Stock
Editor's Pick

Trump FDA nominee turns vaccine question on Dem, recalling controversial Biden decision

by March 6, 2025
written by March 6, 2025

President Donald Trump’s choice to lead the Food and Drug Administration (FDA) flipped a question about vaccine processes around on a top Democratic senator during his confirmation hearing on Thursday, advising them to ask former President Joe Biden why he skipped a key step when it came to the COVID-19 booster. 

Dr. Marty Makary, Johns Hopkins School of Medicine professor and former Fox News medical contributor, went before the Senate Committee on Health, Education, Labor and Pensions (HELP), during which he answered questions regarding vaccines, chronic illness, food safety and abortion. 

‘So if you are confirmed, will you commit to immediately reschedule that FDA Vaccine Advisory Committee meeting to get the expert views?’ Sen. Patty Murray, D-Wash., asked Trump’s FDA pick. 

Her question came in reference to an FDA vaccine meeting that was reportedly postponed at the last minute. 

‘I would reevaluate which topics deserve a convening of the advisory committee members on [Vaccines and Related Biological Products Advisory Committee] and which may not require a convening,’ Makary replied, noting he was not a part of the decision. 

Asked again by Murray, the FDA commissioner nominee said, ‘Well, you can ask the Biden administration that chose not to convene the committee meeting for the COVID vaccine booster.’

In 2021, Biden’s administration notably pushed through FDA approval for a COVID-19 booster for everyone over the age of 18. Per a press release at the time, ‘The FDA did not hold a meeting of the Vaccines and Related Biological Products Advisory Committee on these actions as the agency previously convened the committee for extensive discussions regarding the use of booster doses of COVID-19 vaccines and, after review of both Pfizer’s and Moderna’s EUA requests, the FDA concluded that the requests do not raise questions that would benefit from additional discussion by committee members.’

At the time, committee member Dr. Paul Offit, director of the Vaccine Education Center at Children’s Hospital of Philadelphia remarked, ‘We’re being asked to approve this as a three-dose vaccine for people 16 years of age and older, without any clear evidence if the third dose for a younger person when compared to an elderly person is of value.’

Fox News Digital asked Murray whether she was similarly concerned by Biden’s decision. The senator said in a statement, ‘In 2022, I had confidence that our public health agencies were following the latest science and listening to public health experts. I do not have that confidence now.’

‘We’re talking about Trump and RFK Jr. canceling a routine meeting that has taken place annually, for at least 30 years, to make recommendations for which influenza strains should be included in the flu vaccines for the upcoming flu season – there has been zero justification for its cancellation or any information about when it would be rescheduled,’ she continued. ‘The flu vaccine is safe, effective, and lifesaving – we need this advisory committee to meet so manufacturers have enough time to prepare the correct vaccines.’

Ahead of the Thursday hearing, Murray and fellow HELP Democratic Sens. Tammy Baldwin of Wisconsin and Angela Alsobrooks of Maryland penned a letter to Makary, telling him, ‘We intend to use your nomination hearing next week to understand whether you support this ill-informed measure to slow critical public health decision-making.’ 

HELP Chairman Bill Cassidy, R-La., also inquired about the postponed meeting, asking Makary, ‘How will you ensure that advisory committees remain objective, transparent and still benefiting from the necessary expertise of external experts?’

The nominee told Cassidy, ‘You have my commitment to review what the committees are doing [and] how they’re being used.’

‘As you know, I was critical when that committee was not convened at all during one of the COVID booster guidance decisions by the FDA,’ Makary noted. 

He recalled that FDA leadership ‘at the time argued that they’re advisory, and we don’t have to convene them. That was repeatedly, throughout the Biden administration.’

This post appeared first on FOX NEWS
0 comment
0
FacebookTwitterPinterestEmail

previous post
Trump’s ‘Golden Dome’ will need Manhattan Project-scale whole-of-government effort, Space Force general warns
next post
Trump wants ‘activist’ groups that sue the government to put up money if they lose

related articles

Recess on ice as Republicans hunker down for...

August 1, 2025

Trump moves nuclear submarines weeks after praising sub’s...

August 1, 2025

WATCH: Trump says he is hopeful Hillary Clinton...

August 1, 2025

Iran says it has ‘plenty of scientists’ left...

August 1, 2025

Trump endorses ‘MAGA warrior’ for RNC chairman after...

August 1, 2025

Trump repositions 2 nuclear submarines after ‘highly provocative’...

August 1, 2025

Kavanaugh cites 3 presidents in explaining Supreme Court’s...

August 1, 2025

China’s growing nuclear arsenal aims to break US...

August 1, 2025

Trump ally Bukele’s party amends El Salvador constitution...

August 1, 2025

Trump takes jab at GOP senator, urging Republicans...

August 1, 2025
Enter Your Information Below To Receive Free Trading Ideas, Latest News, And Articles.


Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

Latest News

  • Medvedev warns Trump’s new deadline to end Russia-Ukraine conflict is a ‘step towards war’

    July 29, 2025
  • EURUSD and GBPUSD: EURUSD exceeds last week’s high

    August 19, 2024
  • Trump, Putin agree to begin ceasefire negotiations in Middle East, White House says

    March 18, 2025
  • Dogecoin and Shiba Inu are sinking lower and lower

    August 28, 2024
  • Inside the Situation Room, where Trump and his national security team are weighing next steps on Iran

    June 20, 2025

Popular Posts

  • 1

    Secret Service admits leaning on ‘state and local partners’ after claim it ignored Trump team’s past requests

    July 21, 2024
  • 2

    Five more House Democrats call on Biden to drop out, third US senator

    July 19, 2024
  • 3

    Elon and Vivek should tackle US funding for this boondoogle organization and score a multimillion dollar win

    December 4, 2024
  • 4

    Forex Profit Calculator: Maximize Your Trading Potential

    July 10, 2024
  • 5

    Biden calls to ‘lower the temperature’ then bashes Trump in NAACP speech

    July 17, 2024

Categories

  • Economy (829)
  • Editor's Pick (5,602)
  • Investing (634)
  • Stock (867)

Latest Posts

  • House GOP demands Secret Service director face accountability in new resolution: ‘Must be fired now’

    July 22, 2024
  • TSLA Stock Prediction: Major Rally and Future Projections

    August 29, 2024
  • Wes Moore, considered a rising star among Democratic governors, endorses Kamala Harris

    July 22, 2024

Recent Posts

  • Federal judge partially blocks Trump’s effort to deny funding to pro-DEI public schools

    April 24, 2025
  • Why JPMorgan Chase is prepared to sue the U.S. government over Zelle scams

    September 29, 2024
  • NIH director, after Trump nominates RFK Jr. for HHS secretary, says discouraging vaccinations is ‘disturbing’

    November 19, 2024

Editor’s Pick

  • Republican senator says Trump should not pardon Hunter Biden

    November 8, 2024
  • Israel’s actions against Iran create strategic opportunity for US in nuclear talks, experts say

    June 14, 2025
  • ‘Moana 2’ tops $1 billion, extending Disney’s box office domination

    January 22, 2025
  • About us
  • Contacts
  • Privacy Policy
  • Terms & Conditions

Disclaimer: moneyrisetoday.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2025 moneyrisetoday.com | All Rights Reserved

Money Rise Today – Investing and Stock News
  • Economy
  • Editor’s Pick
Money Rise Today – Investing and Stock News
  • Investing
  • Stock